EUVIMEDEUVIMED entdecken
Crossref

Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality

Pinkal Desai iD, Ying Zhou, Justin Grenet, Samuel K Handelman, Cynthia M Crispino, Laura N Tarbay, Eric A Whitsel, Gail Roboz, Ana Barac, Michael Honigberg, Alexander Bick, Garnet Anderson und 13 weitere

Cancer · 15.11.2024 · 130 (22) · 3879-3887

DOI: 10.1002/cncr.35455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 16.07.2024. Verfasst von Pinkal Desai und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Weill Cornell Medical School, New York, New York, USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Breast Neoplasms, Colorectal Neoplasms, Chromosome Aberrations. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on solid tumor risk and mortality can shed light on novel cancer pathways.

Methods

The authors analyzed whole genome sequencing data from the Trans‐Omics for Precision Medicine Women’s Health Initiative study ( n = 10,866). They investigated the presence of CHIP and mCA and their association with the development and mortality of breast, lung, and colorectal cancers.

Results

CHIP was associated with higher risk of breast (hazard ratio [HR], 1.30; 95% confidence interval [CI], 1.03–1.64; p = .02) but not colorectal ( p = .77) or lung cancer ( p = .32). CHIP carriers who developed colorectal cancer also had a greater risk for advanced‐stage ( p = .01), but this was not seen in breast or lung cancer. CHIP was associated with increased colorectal cancer mortality both with (HR, 3.99; 95% CI, 2.41–6.62; p < .001) and without adjustment (HR, 2.50; 95% CI, 1.32–4.72; p = .004) for advanced‐stage and a borderline higher breast cancer mortality (HR, 1.53; 95% CI, 0.98–2.41; p = .06). Conversely, mCA (cell fraction [CF] >3%) did not correlate with cancer risk. With higher CFs (mCA >5%), autosomal mCA was associated with increased breast cancer risk (HR, 1.39; 95% CI, 1.06–1.83; p = .01). There was no association of mCA (>3%) with breast, colorectal, or lung mortality except higher colon cancer mortality (HR, 2.19; 95% CI, 1.11–4.3; p = .02) with mCA >5%.

Conclusions

CHIP and mCA (CF >5%) were associated with higher breast cancer risk and colorectal cancer mortality individually. These data could inform on novel pathways that impact cancer risk and lead to better risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisBreast NeoplasmsColorectal NeoplasmsChromosome AberrationsMosaicismHumansFemaleAgedMiddle AgedIncidenceLung NeoplasmsMaleNeoplasmsWhole Genome Sequencing

Stichwörter der Autor:innen

breast cancerclonal hematopoiesisclonal hematopoiesis of indeterminate potential (CHIP)colorectal cancermosaic chromosomal alterationssolid tumor mortalitysolid tumors risk

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Weill Cornell Medical School, New York, New York, USA.
  • Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Oregon Health and Science University, Portland, USA.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine at the University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

ORCID-Profile: Pinkal Desai, Xiaolong Ma, Michael Simon

Förderung

  • NCI NIH HHS

Zitieren

APA

Desai, P., Zhou, Y., Grenet, J., Handelman, S. K., Crispino, C. M., Tarbay, L. N., Whitsel, E. A., Roboz, G., Barac, A., Honigberg, M., Bick, A., Anderson, G., Wactawski-Wende, J., Jakubek Swartzlander, Y. A., Bacon, J., Wong, J., Ma, X., Scheet, P., Li, Z., …, & Simon, M. (2024). Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality. Cancer, 130(22), 3879-3887. https://doi.org/10.1002/cncr.35455

Vancouver

Desai P, Zhou Y, Grenet J, Handelman SK, Crispino CM, Tarbay LN, et al. Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality. Cancer. 2024;130(22):3879-3887. doi:10.1002/cncr.35455

BibTeX
@article{Desai2024,
  author = {Desai, Pinkal and Zhou, Ying and Grenet, Justin and Handelman, Samuel K and Crispino, Cynthia M and Tarbay, Laura N and Whitsel, Eric A and Roboz, Gail and Barac, Ana and Honigberg, Michael and Bick, Alexander and Anderson, Garnet and Wactawski-Wende, Jean and Jakubek Swartzlander, Yasminka A and Bacon, Jason and Wong, Justin and Ma, Xiaolong and Scheet, Paul and Li, Zichan and Kasi, Pashtoon and Prentice, Ross and Auer, Paul and Manson, JoAnn E and Reiner, Alexander and Simon, Michael},
  title = {Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {22},
  pages = {3879--3887},
  doi = {10.1002/cncr.35455}
}
Kostenlos starten →